C. Reichel et al., MOLECULAR-CLONING AND EXPRESSION OF A 2-ARYLPROPIONYL-COENZYME-A EPIMERASE - A KEY ENZYME IN THE INVERSION METABOLISM OF IBUPROFEN, Molecular pharmacology, 51(4), 1997, pp. 576-582
The 2-arylpropionic acid derivatives, including ibuprofen, are the mos
t widely used anti-inflammatory analgesic cyclooxygenase inhibitors. T
he (-)-R-enantiomer, which is inactive in terms of cyclooxygenase inhi
bition, is epimerized in vivo via the 2-arylpropionyl-coenzyme A (CoA)
epimerase to the cyclooxygenase-inhibiting (+)-S-enantiomer. The mole
cular biology of the epimerization pathway is largely unknown. To clar
ify this mechanism, the sequence of the 2-arylpropionyl-CoA epimerase
was identified, and the enzyme cloned and expressed. A cDNA clone enco
ding the 2-aryipropionyl-CoA epimerase was isolated from a rat liver c
DNA library. The nucleotide and the deduced amino acid sequence of thi
s enzyme was determined. Significant amino acid sequence similarity wa
s found between the rat epimerase and carnitine dehydratases from Caen
orhabditis elegans (41%) and Escherichia coli (27%). A bacterial expre
ssion system (E. coli strain M15[pREP4]) was used to express the epime
rase protein, representing up to 20-30% of the total cellular E. coil
protein. The expression of the epimerase was confirmed with Western bl
ots using specific anti-epimerase antibodies and by measuring the rate
of inversion of (R)-ibuprofenoyl-CoA. Northern blot analysis revealed
a prominent 1.9-kb mRNA transcript in different rat tissues. In addit
ion to its obvious importance in drug metabolism the homology of the e
pimerase with carnitine dehydratases from several species suggests tha
t this protein, which up to now has only been characterized as having
a role in drug transformation, has a function in lipid metabolism.